作者:Alexandre Erdmann、Yoann Menon、Christina Gros、Nicolas Molinier、Natacha Novosad、Arnaud Samson、Jean-Marc Gregoire、Christophe Long、Frédéric Ausseil、Ludovic Halby、Paola B. Arimondo
DOI:10.1016/j.bmc.2015.06.066
日期:2015.9
DNA methylation, an epigenetic modification regulating gene expression, is a promising target in cancer. In an effort to identify new non nucleosidic inhibitors of DNA methyltransferases, the enzymes responsible for DNA methylation, we carried out a high-throughput screening of 66,000 chemical compounds based on an enzymatic assay against catalytic DNMT3A. A family of propiophenone derivatives was identified. After chemical optimization and structure activity relationship studies, a new inhibitor ( 33) was obtained with an EC50 of 2.1 mu M against DNMT3A. The mechanism of inhibition of the compound was investigated as it forms a reactive Michael acceptor group in situ. Thereby, the Michael acceptor 20 was identified. This compound was further characterized for its biological activity in cancer cells. (C) 2015 Elsevier Ltd. All rights reserved.